Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Belantamab mafodotin

😃Good
Catalog No. T77903Cas No. 2050232-20-5
Alias GSK2857916, GSK 2857916, Belantamab mafodotin-blm

Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA) that enhances immune cell infiltration and activation within tumors and delays tumor growth. It is used in studies of multiple myeloma.

Belantamab mafodotin

Belantamab mafodotin

😃Good
Catalog No. T77903Alias GSK2857916, GSK 2857916, Belantamab mafodotin-blmCas No. 2050232-20-5
Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA) that enhances immune cell infiltration and activation within tumors and delays tumor growth. It is used in studies of multiple myeloma.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$297In StockIn Stock
5 mg$778-In Stock
10 mg$1,230-In Stock
25 mg$1,830-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.14% (SEC-HPLC)
Contact us for more batch information

Product Introduction

Bioactivity
Description
Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA) that enhances immune cell infiltration and activation within tumors and delays tumor growth. It is used in studies of multiple myeloma.
Targets&IC50
BCMA (human):1 nM (Kd)
In vitro
Belantamab mafodotin is an immune conjugate (ADC) that targets B cell maturation antigens.
The Kd value of Belantamab mafodotin binding human BCMA protein was 1 nM.
Belantamab mafodotin induces G2/M phase arrest in multiple myeloma cells in a dose - and time-dependent manner. [1]
In vivo
Belantamab mafodotin significantly improved survival in mice with OPM2 tumors. [1]
SynonymsGSK2857916, GSK 2857916, Belantamab mafodotin-blm
Reactivity
Human
Verified Activity
Immobilized Human BCMA-ECD-His at 2 μg/mL can bind Belantamab mafodotin. The EC50 is 0.02634 μg/mL
Application
Functional assay
Antibody Type
Monoclonal
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
MMAF
Antigen Details
Gene ID
Uniprot ID
TargetTNFRSF17/BCMA/CD269
Chemical Properties
Molecular Weight146.06 kDa
Cas No.2050232-20-5
Antibody Information
IsotypeIgG1 kappa-McMMAF
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Belantamab mafodotin | purchase Belantamab mafodotin | Belantamab mafodotin cost | order Belantamab mafodotin | Belantamab mafodotin in vivo | Belantamab mafodotin in vitro | Belantamab mafodotin molecular weight